Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
153.65Prev. Close
153.65Volume
2,20,867Total traded value
3.23 CrUpper Circuit
153.51Lower Circuit
138.89Fundamentals
| Market Cap | ₹1,131Cr |
| ROE | -20.84% |
| P/E Ratio(TTM) | 9.19 |
| EPS(TTM) | 16.68 |
| P/B Ratio | 9.76 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.07 |
| Book Value | 15.72 |
| Debt to Equity | 0.97 |
| Face Value | 10 |
Understand Fundamentals
Financials
About MEGASOFT Limited
Megasoft Limited has strategically transitioned from the IT business to focus on high-potential sectors like pharmaceuticals and defence, aiming for sustainable growth. The company is committed to establishing a strong foothold in the defence sector by leveraging its technical expertise, innovative capabilities, and strategic partnerships. As part of its strategy, the company now holds a 40% stake in Extrovis AG, an associate company based in Switzerland.;
| Parent Organisation | MEGASOFT Limited |
| Managing Director | Mr. G. Kumar |
| NSE Symbol | MEGASOFT |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 102.92 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.00 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.72 | ||
| Wockhardt | NA (0.00%) | -151.40 |